NCPA: Mail Order Waste All Too Common; Documented by Federal Officials
PRESS RELEASE
Alexandria, Va. March 5, 2013 - Pharmacist and Senior Vice President for Government Affairs John Coster, RPh, PhD of the
"Community pharmacists, one of America's
"PCMA has a lot of words about this issue, but we have the evidence. Talk to people who have dealt with mail, and more often than not, they will tell you about their own personal story—or that of a relative—having a closet full of medications that they didn't order and can't use—all because of mail order companies' desire to pump as much medications into the mail—including controlled substances—to collect reimbursement for the cost of the unwanted or unneeded drugs from the plan sponsor, dispensing fees, and lucrative manufacturer rebates.
"Medicare officials, reflecting their concerns and those raised by pharmacists, attested just last month to consumer complaints regarding mail order waste. This follows previous statements and reports by federal health officials affirming mail order waste, such as in the provision of diabetes test supplies.
"The study released by the PBM lobby today actually provides fresh evidence of the outsized role that mail order plays in pharmaceutical waste. While mail order accounted for 19 percent of Medicare prescriptions reviewed in the study, those prescriptions accounted for 32 percent of the waste. In other words, mail order prescriptions continue to generate considerably more wastage per prescription than other pharmacy options.
"While mail order waste may be alive and well, the good news is that policymakers and plan sponsors can adopt simple steps to mitigate this problem. For starters, patients should be able to choose a pharmacy that best meets their own health needs, without co-pay incentives for mail order. A face-to-face health care experience makes it far less likely that patients would be auto-shipped medications that they didn't request and don't need."
Federal officials document waste through mail order auto-shipping:
- Medicare has received complaints from beneficiaries about auto-shipping of excessive or unneeded medical products, noting that: "CMS has received complaints that beneficiaries have had medications delivered that had been previously discontinued or were otherwise unwanted and unnecessary at the time of delivery. ... Once the prescription is delivered, pharmacies are unable to return the medication to stock and generally do not reverse the claim if the patient does not want the prescription. Consequently, automatic delivery practices are potentially generating significant waste and unnecessary additional costs for beneficiaries and the Part D program overall. ... In a related issue, CMS has received complaints indicating that some mail-service pharmacies automatically deliver new prescriptions that were phoned in or e-prescribed from the physician's office without confirming that the patient wants the prescription filled and delivered."
- The Office of Inspector General has documented similar incidences in the provision of diabetes test supplies (DTS). Recently, in front of the House Small Business Committee, a Medicare official testified that from a selected group of beneficiaries that ceased ordering DTS in 2011, 60 percent of these beneficiaries had over 10 months' worth of diabetes testing supplies on hand, likely as a result of mail order auto-shipping.
Study Shows Medicare Savings when Local Pharmacies Fill 90-Day Prescriptions, Compared with Mail Order. A
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025